Vanguard Global Advisers »

Krystal Biotech shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 11k 258.32

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Krystal Biotech

FMR
BlackRock
venBio Select Advisor
Vanguard Group
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Soleus Capital Management
Capital World Investors
Redmile Group
Geode Capital Management
Hood River Capital Management
Frazier Life Sciences Management
Dimensional Fund Advisors
Bellevue Group

View all funds holding Krystal Biotech